Posts for Ticker ‘SVA’

Top Day Trader Alerts (FNM, FRE, HOV, INWK, JAVA, ORCL, SEPR, SVA, ZUMZ)

These are this Thursday’s top day trader and active trader alert stocks.  We have links through to each with more detailed price/volume analysis over at VSinvestor.com:

Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE) are bouncing by over 10% this morning now that equities have stopped the drop for now.

Hovnanian Enterprises Inc. (NYSE: HOV) is down about 10% … maybe all those ‘great home sales figures’ are either not so great or are not sustainable.

InnerWorkings Inc. (NASDAQ: INWK) is down sharply on an earnings warning.

Sun Microsystems Inc. (NASDAQ: JAVA) is down, but not as bad as you might think, on the EU probe of the Oracle Corp. (NASDAQ: ORCL) buyout…. Silly children must be in charge over there.

Sepracor, Inc. (NASDAQ: SEPR) is already at exponential trading volume on the buyout news.

Sinovac Biotech Ltd. (AMEX: SVA) is challenging $10.00 again… China approved it for a vaccine against swine flu for the Chinese market.

Zumiez Inc. (NASDAQ: ZUMZ) is up over 10% after negative same store sales were not as bad even at -12.1%… it caught 3 analyst upgrades.

You can join our open email distribution list which goes out several times per week if you wish to be notified by email when the top day trader alerts hit, along with news of IPO’s, key offerings, guru investor data on Buffett and others, mergers, and more.

JON C. OGG
SEPTEMBER 3, 2009

Posted on: September 3, 2009 – 9:04 am in After-Hours Activity, Pre-Market Activity, , , , , , , , ,

Top Day Trader Alerts (MRVL, OVTI, DELL, AIG, ARUN, SVA)

These are this Friday morning’s top day trader and active trader alerts with links through to each story with more detailed price and volume analysis over at VSInvestor.com:

Marvell Technology Group Ltd. (NASDAQ: MRVL) is hitting new 52-week highs and is now a triple off lows after its strong report.

OmniVision Technologies Inc. (NASDAQ: OVTI) is hitting new 52-week highs on very strong guidance.

Dell Inc. (NASDAQ: DELL) is actually up about 10% on earnings if you consider where it was before the earnings report leaked right before the closing bell.

American International Group, Inc. (NYSE: AIG) is up about 10% again on several bits of ongoing news.

Aruba Networks, Inc. (NASDAQ: ARUN) is hitting a new 52-week high after earnings.

Sinovac Biotech Ltd. (AMEX: SVA) is soaring to new 52-week highs on swine flu pact news in Beijing….

If you wish to be notified by email when the top day trader alerts hit, along with news of IPO’s, key offerings, guru investor data on Buffett and others, mergers, and more, you can join our open email distribution list which goes out several times per week.

-The 24/7 Wall Street Team

Posted on: August 28, 2009 – 8:57 am in After-Hours Activity, Pre-Market Activity, Trading Alert, , , , , ,

Biotech News Day (February 4, 2008) (AMAG, AOB, AMGN, CELG, MNTA, OMRI, SVA, STEM)

Below are some of the top issues affecting biotech shares today:

  • AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company developing iron compounds to treat anemia, saw shares rise 4% to $56.00 after brokerage firm Robert W. Baird initiated coverage with an OUTPERFORM rating.
  • American Oriental Bioengineering Inc. (NYSE:AOB) shares are down almost 7% at mid-day with relative high volume trading to $9.50 on no real news.
  • Amgen Inc. (NASDAQ:AMGN) stock shows no reaction to deal with Japanese drug giant Takeda Pharmaceutical. Takeda is to purchase Amgen’s Japanese unit for up to $902 million plus royalties on sales in exchange for access to 13 of Amgen’s new drugs. Amgen hopes this will curb costs and provide cash as their high-selling anemia drug sales slow due to safety issues. 
  • Celgene Corporation (NASDAQ:CELG) shares are down $1.76 to $57.94 at mid-day. Although earnings reported last Thursday met Wall Street expectations, the outlook for the success of its multiple myeloma cancer treatment, Revlimid, is mixed. Today, the company released Phase II data and news for its psoriasis drug CC-10004. The recent study showed positive results and the company announced plans to increase dosages. 
  • Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) shares continued to take a beating after they announced their earnings release date this morning. They had a rough quarter after the FDA rejected their genetic blood-thinner in November, losing about 60% of its share price. Shares are down $0.37 to $7.54 at mid-day. 
  • Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI) shares are slightly recovering today after a sharp plummet over the last 2 weeks following the FDA approval for competitor ZymoGenetics’ (ZGEN) Recothrom, that will compete with Omrix’s Evithrom in the thrombin drug market. Omrix announced last Friday that their CFO is resigning. Shares are up 4% to $21.27 on relatively heavy trading volume at mid-day. A month ago, shares were trading at over $30. 
  • Sinovac Biotech Ltd. (AMEX:SVA), the Chinese vaccine provider, has shares up over 5% to $4.11 at mid-day after Sinovec announced the private placement of 2,500,000 common shares for $9.75 million to Sansar Capital Management. 
  • StemCells Inc. (NASDAQ:STEM) stock continued to rise after news last Thursday that it plans to collaborate with Casey Eye Institute to study their leading product candidate, HuCNS-SC, a probable treatment for retinal degeneration which is a leading cause of blindness. Shares are up over 15% at mid-day to $1.77.

Rachel Lopez
February 4, 2008

Posted on: February 4, 2008 – 2:41 pm in Biotech, , , , , , , ,